<DOC>
	<DOCNO>NCT02762448</DOCNO>
	<brief_summary>Interferon-free Antiviral Treatment HCV-Positive Genotype 1b Related Indolent non-Hodgkin Lymphomas Patients Using Daclatasvir Asunaprevir : A Pilot Study</brief_summary>
	<brief_title>Interferon-free Antiviral Treatment HCV-Positive Genotype 1b Related Indolent Non-Hodgkin Lymphomas</brief_title>
	<detailed_description>Prospectively collect case NHL ( n=10 ) , HCV genotype 1b related NHL , treat ASV ( 200 mg twice daily ) + DCV ( 60 mg daily ) 24 week The patient observe followed determine whether regression NHL antiviral treatment . Conventional chemotherapy initiate shortly case without regression .</detailed_description>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Antiviral Agents</mesh_term>
	<criteria>1 . Men woman 2 . 18 70 year age 3. Who chronic HCV genotype 1b infection 4 . An HCV RNA level 105 IU per milliliter high 5 . Being diagnose low grade B cell nonHodgkin lymphoma 1 . Patients hepatitis B virus infection , 2 . Other liver diseases 3 . HIV infection , 4 . Preexisting HCV variant NS5A domain include Q30R , L31 M/V , Y93C/N 5 . Evidence cirrhosis , document mean either liver biopsy assessment image result .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>